Cargando…

Long-term effects of medical management on growth and weight in individuals with urea cycle disorders

Low protein diet and sodium or glycerol phenylbutyrate, two pillars of recommended long-term therapy of individuals with urea cycle disorders (UCDs), involve the risk of iatrogenic growth failure. Limited evidence-based studies hamper our knowledge on the long-term effects of the proposed medical ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Posset, Roland, Garbade, Sven F., Gleich, Florian, Gropman, Andrea L., de Lonlay, Pascale, Hoffmann, Georg F., Garcia-Cazorla, Angeles, Nagamani, Sandesh C. S., Baumgartner, Matthias R., Schulze, Andreas, Dobbelaere, Dries, Yudkoff, Marc, Kölker, Stefan, Zielonka, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371674/ https://www.ncbi.nlm.nih.gov/pubmed/32686765 http://dx.doi.org/10.1038/s41598-020-67496-3

Ejemplares similares

Early prediction of phenotypic severity in Citrullinemia Type 1
por: Zielonka, Matthias, et al.
Publicado: (2019)

Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency
por: Scharre, Svenja, et al.
Publicado: (2022)

Unmet Needs of Parents of Children with Urea Cycle Disorders
por: Scharping, Mara, et al.
Publicado: (2022)

Incidence, disease onset and short-term outcome in urea cycle disorders –cross-border surveillance in Germany, Austria and Switzerland
por: Nettesheim, Susanne, et al.
Publicado: (2017)

FDA orphan drug designations for lysosomal storage disorders – a cross-sectional analysis
por: Garbade, Sven F., et al.
Publicado: (2020)

Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study
por: Husson, Marie-Caroline, et al.
Publicado: (2016)

Evaluation of Right Ventricular Function in Patients with Propionic Acidemia—A Cross-Sectional Study
por: Kovacevic, Alexander, et al.
Publicado: (2023)

Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase
por: Zielonka, Matthias, et al.
Publicado: (2018)

Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: a meta-analysis
por: Boy, Nikolas, et al.
Publicado: (2020)

Impact of the SARS‐CoV‐2 pandemic on the health of individuals with intoxication‐type metabolic diseases—Data from the E‐IMD consortium
por: Mütze, Ulrike, et al.
Publicado: (2022)

QDPR homologues in Danio rerio regulate melanin synthesis, early gliogenesis, and glutamine homeostasis
por: Breuer, Maximilian, et al.
Publicado: (2019)

Cross-sectional quantitative analysis of the natural history of TUBA1A and TUBB2B tubulinopathies
por: Schröter, Julian, et al.
Publicado: (2020)

Combined Newborn Screening Allows Comprehensive Identification also of Attenuated Phenotypes for Methylmalonic Acidurias and Homocystinuria
por: Schnabel, Elena, et al.
Publicado: (2023)

Machine Learning Methods Improve Specificity in Newborn Screening for Isovaleric Aciduria
por: Zaunseder, Elaine, et al.
Publicado: (2023)

Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001–2013
por: Unsinn, Caroline, et al.
Publicado: (2016)

A cross-sectional controlled developmental study of neuropsychological functions in patients with glutaric aciduria type I
por: Boy, Nikolas, et al.
Publicado: (2015)

High blood pressure, a red flag for the neonatal manifestation of urea cycle disorders
por: Teufel, Ulrike, et al.
Publicado: (2019)

Maternal Vitamin B(12) Deficiency Detected by Newborn Screening—Evaluation of Causes and Characteristics
por: Reischl-Hajiabadi, Anna T., et al.
Publicado: (2022)

Sudden neonatal death in individuals with medium-chain acyl-coenzyme A dehydrogenase deficiency: limit of newborn screening
por: Mütze, Ulrike, et al.
Publicado: (2022)

Citrulline in the management of patients with urea cycle disorders
por: Imbard, Apolline, et al.
Publicado: (2023)

Opportunities and challenges in machine learning‐based newborn screening—A systematic literature review
por: Zaunseder, Elaine, et al.
Publicado: (2022)

Multimodal imaging in urea cycle-related neurological disease – What can imaging after hyperammonemia teach us?
por: Sen, Kuntal, et al.
Publicado: (2020)

Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue
por: Sen, Kuntal, et al.
Publicado: (2021)

Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders
por: Monostori, Péter, et al.
Publicado: (2017)

BLOOD AMMONIA AND GLUTAMINE AS PREDICTORS OF HYPERAMMONEMIC CRISES IN UREA CYCLE DISORDER PATIENTS
por: Lee, Brendan, et al.
Publicado: (2014)

Real‐world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid‐free formulas in France and Germany: A retrospective observational study
por: de Lonlay, Pascale, et al.
Publicado: (2021)

Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience
por: Kölker, Stefan, et al.
Publicado: (2022)

Untargeted Metabolomic Profiling Reveals Multiple Pathway Perturbations and New Clinical Biomarkers in Urea Cycle Disorders
por: Burrage, Lindsay C., et al.
Publicado: (2019)

Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis
por: Kožich, Viktor, et al.
Publicado: (2020)

Cross-sectional observational study of 208 patients with non-classical urea cycle disorders
por: Rüegger, Corinne M., et al.
Publicado: (2013)

The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study
por: Märtner, E. M. Charlotte, et al.
Publicado: (2021)

Publisher Correction: The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study
por: Märtner, E. M. Charlotte, et al.
Publicado: (2021)

U-IMD: the first Unified European registry for inherited metabolic diseases
por: Opladen, Thomas, et al.
Publicado: (2021)

Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition?
por: Vamecq, Joseph, et al.
Publicado: (2015)

Results from a Nationwide Cohort Temporary Utilization Authorization (ATU) Survey of Patients in France Treated with Pheburane(®) (Sodium Phenylbutyrate) Taste-Masked Granules
por: Kibleur, Yves, et al.
Publicado: (2014)

Urea Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion Secondary to Amyotrophic Lateral Sclerosis
por: Martín, Francisco Javier Mena, et al.
Publicado: (2020)

Novel challenges in spinal muscular atrophy – How to screen and whom to treat?
por: Saffari, Afshin, et al.
Publicado: (2018)

Treatment of Wounds with Urea
por: Stonham, F. V.
Publicado: (1940)

A case report of hamartomatous polyposis in an individual with Neurofibromatosis type 1
por: Boulier, Kristin, et al.
Publicado: (2018)

Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis
por: Pfeil, Johannes, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jtiduqc7tdbvk70itink0mcrdu